This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bio-Reference Laboratories Inc (BRLI)

NASDAQ: Health Care

Company Balance Sheet
Oct 2014 Oct 2013 Oct 2012 Oct 2011
Assets
Cash and Equivalents 17.51M 17.95M 25.14M 22.01M
Receivables 263.35M 206.26M 153.25M 148.06M
Inventories n.a. 19.10M 14.90M 9.69M
Other Current Assets 0.00 9.42M 5.37M 4.46M
Total Current Assets 280.85M 294.88M 223.58M 206.78M
Property, Plant & Equipment, Gross 66.39M 133.60M 102.70M 81.72M
Accumulated Depreciation & Depletion n.a. 67.95M 52.26M 38.15M
Property, Plant & Equipment, Net 66.39M 65.65M 50.44M 43.57M
Intangibles 49.59M 16.32M 6.32M 6.90M
Other Non-Current Assets 82.03M 7.42M 6.80M 1.61M
Total Non-Current Assets 198.01M 126.65M 89.25M 76.48M
Liabilities & Shareholder Equity
Total Assets 478.86M 421.53M 312.82M 283.26M
Accounts Payable 71.17M 64.05M 41.29M 38.99M
Short Term Debt 0.00 5.68M 4.42M 4.27M
Other Current Liabilities 0.00 18.29M 9.75M 8.85M
Total Current Liabilities 104.55M 133.76M 71.95M 82.51M
Long Term Debt 22.05M 3.67M 4.16M 4.63M
Deferred Income Taxes n.a. 0.00 0.00 0.00
Other Non-Current Liabilities 33.37M 1.79M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 55.42M 16.17M 13.63M 10.98M
Total Liabilities 159.96M 149.93M 85.58M 93.49M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 318.90M 271.60M 227.25M 189.77M
Common Par n.a. 277.00K 277.00K 280.00K
Additional Paid In Capital 0.00 39.43M 40.91M 45.58M
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 231.89M 186.06M 143.91M
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments 318.90M 0.00 0.00 0.00
Total Capitalization 340.95M 275.26M 231.41M 194.39M
Total Equity 318.90M 271.60M 227.25M 189.77M
Total Liabilities & Stock Equity 478.86M 421.53M 312.82M 283.26M
Total Common Shares Outstanding 27.73M 27.68M 27.71M 27.95M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 0.00 0.00 0.00
Basic Weighted Shares Outstanding 27.72M 27.69M 27.74M 27.97M
Diluted Weighted Shares Outstanding 27.86M 27.85M 27.92M 28.21M
Number of Employees NA 3338 2726 2438
Number of Part-Time Employees NA 1089 838 717
BRLI News

BRLI Bio-Reference Laboratories Inc

Analysts Ratings for BRLI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET BRLI ANALYST REPORT

Brokerage Partners

BRLI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs